#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4419005	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R10 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
2.	ALA4419006	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R14 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
3.	ALA4419020	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R46 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
4.	ALA4419030	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R46 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of picrotoxinin-induced intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
5.	ALA4419031	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R47 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of brucine-induced intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
6.	ALA4419032	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R40 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of cohumulone-induced intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
7.	ALA4419033	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R43 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of aristolochic acid-induced intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
8.	ALA4419034	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R1 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of trans-isocohumulone-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
9.	ALA4419035	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R3 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of chloroquine-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
10.	ALA4419036	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R4 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of colchicine-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
11.	ALA4419037	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R8 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of chloramphenicol-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
12.	ALA4419038	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R9 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of ofloxacin-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
13.	ALA4419039	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R10 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of strychnine-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
14.	ALA4419040	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R13 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of denatonium benzoate-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
15.	ALA4419041	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R14 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of aristolochic acid-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
16.	ALA4419042	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R16 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of D-salicin-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
17.	ALA4419043	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R38 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of phenylthiocarbamide-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
18.	ALA4419044	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R39 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of epigallocatechin galiate-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
19.	ALA4419045	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R44 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of aristolochic acid-induced intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data
20.	ALA4419046	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R49 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of cromolyn-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2	ALA4418912	cell-based format	Patent Bioactivity Data